Alternatives to Osteoporosis Drugs Bisphosphonates
Links shared publicly online about this topic.
- 900total visits
Alternatives to Osteoporosis Drugs Bisphosphonates
View full resource at emaxhealth.com
Tags: Digestion, Cancer, Esophageal Cancer, Osteoporosis, Osteoporosis Medication, Drug
Most Recently Shared on September 3, 2010 at 9:47 pm By:
Alternatives to Osteoporosis Drugs Bisphosphonates http://bit.ly/dvtzWo
Bisphosphonates improve fixation of dental impants in human bones
news-medical.net — “Millions of people have bad teeth replaced with implants. Often following the procedure, they are unable to chew food for up to six months, until the implant has become fixated in the bone. Now, for the first time, a drug coating that has been tested on humans allows titanium screws to adhere to the bone better and faster. The Link-ping researchers behind the method report that the results are good.” View full resource at news-medical.net
Most Recently Shared on March 3, 2012 at 12:08 am By:
Osteoporosis News: Bisphosphonates improve fixation of dental impants in human bones: Millions of people have ba... http://t.co/D0JFVld3
Medical News: FDA Panel to Weigh Break from Bisphosphonate Use - in Endocrinology, Osteoporosis from MedPage Today
medpagetoday.com — “WASHINGTON -- A joint FDA advisory committee will meet Friday to discuss the risks associated with long-term use of bisphosphonates and whether a drug holiday would help prevent fractures in patient” View full resource at medpagetoday.com
Most Recently Shared on September 15, 2011 at 10:56 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
Medical News: FDA Panel to Weigh Break from Bisphosphonate Use - http://t.co/LRpsHfxK from @medpagetoday #health #medicine
FDA panel unclear on osteoporosis drug labels - CBS News
cbsnews.com — “Labels on bisphosphonates, a type of medication used to treat and prevent osteoporosis, should further clarify how long patients can take them, an FDA advisory panel voted today.” View full resource at cbsnews.com
Most Recently Shared on September 14, 2011 at 10:13 am By:
Joel W. Steelman, MD - The Endoguy Endocrinologist, Physician, Active Health Library, Doctor, and Pediatrician
FDA panel unclear on osteoporosis drug labels - CBS News http://t.co/F2pQOir
FDA advisory panel suggests warning for bisphosphonates but does not specify wording
news-medical.net — “Two independent advisory panels to the Food and Drug Administration (FDA) on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by more than five million women in the United States. They did not however mention the exact words of the safety warnings and did not recommend limiting use of the drugs to a proposed five years. About 11 percent of women 55 and older take the drugs to prevent bone fractures.” View full resource at news-medical.net
Most Recently Shared on September 12, 2011 at 3:09 pm By:
Osteoporosis News: FDA advisory panel suggests warning for bisphosphonates but does not specify wording: Two ind... http://t.co/pV4RZTU
Bisphosphonates in management of osteoporosis: an FDA update « THE "NEW" PROSTATE CANCER INFOLINK
prostatecancerinfolink.net — “Bisphosphonates in management of osteoporosis: an FDA update « THE "NEW" PROSTATE CANCER INFOLINK” View full resource at prostatecancerinfolink.net
Most Recently Shared on September 12, 2011 at 1:54 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Bisphosphonates in management of osteoporosis: an FDA update: Last Friday a U.S. Food & Drug Administration (FDA... http://t.co/cnrxdQE
Osteoporosis Drugs Carry Serious Risks, FDA Says | ThirdAge
thirdage.com — “Osteoporosis drugs called bisphosphonates are associated with serious side effects, including osteonecrosis of the jaw and esophageal cancer” View full resource at thirdage.com
Most Recently Shared on September 12, 2011 at 10:25 am By:
Osteoporosis Drugs Carry Serious Risks, FDA Says http://t.co/eE36a21
Osteoporosis Drug Associated With Serious Side Effects: FDA
ibtimes.com — “Long-term exposure to a class of osteoporosis drugs called bisphosphonates is associated with serious side effects, concluded panels to the Food and Drug Administration (FDA).” View full resource at ibtimes.com
Most Recently Shared on September 12, 2011 at 7:57 am By:
Drugs and Devices OW OW Health
Osteoporosis Drug Associated With Serious Side Effects: FDA - International Business Times: Kansas City St... http://t.co/wHWQnHf #drug
Bisphosphonate Osteoporosis Drugs: FDA Questions Long-term Effects
ibtimes.com — “Biphosphonates, drugs introduced to the market 16 years ago that treats osteoporosis, need labeling to clarify how long patients should take them as data suggests that efficacy decreases while risk increases after some period, panels to the Food and Drug Administration (FDA) voted on Friday.” View full resource at ibtimes.com
Most Recently Shared on September 11, 2011 at 10:22 pm By:
Drugs and Devices OW OW Health
Biphosphonate Osteoporosis Drugs: FDA Questions Long-term Effects - International Business Times: ThirdAge... http://t.co/lofBu0O #drug
Bisphosphonate Osteoporosis Drugs: FDA Questions Long-term Effects
ibtimes.com — “Biphosphonates, drugs introduced to the market 16 years ago that treats osteoporosis, need labeling to clarify how long patients should take them as data suggests that efficacy decreases while risk increases after some period, panels to the Food and Drug Administration (FDA) voted on Friday.” View full resource at ibtimes.com
Most Recently Shared on September 11, 2011 at 9:39 pm By:
Drugs and Devices OW OW Health
Bisphosphonate Osteoporosis Drugs: FDA Questions Long-term Effects: Biphosphonates, drugs introduced to the mark... http://t.co/s1QZD2U
Bisphosphonates - New Labeling Data On Long-term Usage Recommended By FDA Advisory Panel - QualityPoint Technologies
qualitypointtech.net — “Bisphosphonates, medications for the treatment and prevention of osteoporosis and other bone conditions, should have additional data on their labels on treatment duration, an FDA Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee (the Panel) recommended. However, the panel did not go as far as advising that specific time limits be included. Approximately 5 million Americans fill bisphosphonates prescriptions annually, and include such bran” View full resource at qualitypointtech.net
Most Recently Shared on September 10, 2011 at 8:45 pm By:
Bisphosphonates - New Labeling Data On Long-term Usage Recommended By FDA Advisory Panel: Bisphosphonates, medicat... http://t.co/07wDoRQ
FDA Advisers Call for Revised Labels for Osteoporosis Drugs - MSN Health - Medications
health.msn.com — “Research suggests potential health risks associated with long-term use of bisphosphonates” View full resource at health.msn.com
Most Recently Shared on September 9, 2011 at 1:46 pm By:
Osteoporosis Drugs' Safety Subject of FDA Panel: http://t.co/6aQyNga
FDA panels call for clarification on duration of bisphosphonate use
endocrinetoday.com — “The FDA's Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee today voted 17-6 to add clarif” View full resource at endocrinetoday.com
Most Recently Shared on September 9, 2011 at 1:35 pm By:
#FDA panels to discuss long-term risks of #osteoporosis drugs http://ow.ly/6pOk1 #bisphosphonates
FDA reviews safety issues of bisphosphonates for osteoporosis
news-medical.net — “An advisory committee for U.S. Food and Drug Administration meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates amid worry that their long-term use could cause rare fractures of the thighbones and affect the jawbone. The committee will evaluate whether women should temporarily stop using the drugs or use them for only a few years.” View full resource at news-medical.net
Most Recently Shared on September 7, 2011 at 7:54 am By:
Osteoporosis News: FDA reviews safety issues of bisphosphonates for osteoporosis: An advisory committee for U.S.... http://t.co/Ytvr8jT
FDA Committee to Review Osteoporosis Drugs - ABC News
abcnews.go.com — “A U.S. Food and Drug Administration advisory committee meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates.” View full resource at abcnews.go.com
Most Recently Shared on September 6, 2011 at 8:34 pm By:
Drugs and Devices OW OW Health
FDA to Review Safety of Osteoporosis Drugs: Popular medications linked to rare thigh fractures and jawbone death. http://t.co/B7gYyni
FDA Committee to Review Osteoporosis Drugs - ABC News
abcnews.go.com — “A U.S. Food and Drug Administration advisory committee meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates.” View full resource at abcnews.go.com
Most Recently Shared on September 6, 2011 at 5:15 pm By:
Drugs and Devices OW OW Health
FDA Committee to Review Osteoporosis Drug Safety - ABC News: ABC NewsFDA Committee to Review Osteoporosis ... http://t.co/f64eqYm #drug
Advertisement
